Cargando…

Factors affecting cardiovascular morbidity in young FMF patients. A comparative analysis in colchicine treated FMF patients with and without cardiovascular disease

Detalles Bibliográficos
Autores principales:	Roitman, AJ, Zvi, I Ben, Kukuy, O, Livneh, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596969/ http://dx.doi.org/10.1186/1546-0096-13-S1-O47

Ejemplares similares

Colchicine therapy in children with FMF
por: Knieper, A-M, et al.
Publicado: (2015)

Featuring the phenotype of the FMF prototype
por: Ben-Zvi, I, et al.
Publicado: (2015)

P01-031 – Anakinra for colchicine resistant FMF
por: Ben-Zvi, I, et al.
Publicado: (2013)

Toll like receptor 2 is overexpressed in FMF patients during attacks and inhibited by colchicine treatment
por: Ben-David, H, et al.
Publicado: (2015)

P01-029 – Microscopic hematuria in FMF
por: Grabowitz, L, et al.
Publicado: (2013)

Arterial stiffness as a model to dissect chronic inflammation in FMF
por: Kukuy, O, et al.
Publicado: (2015)

P01-027 – Normal HRV in colchicine-resistant FMF patients
por: Nussinovitch, U, et al.
Publicado: (2013)

First report of MEFV duplication in FMF patient
por: Sarrabay, G, et al.
Publicado: (2015)

Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients
por: Salehzadeh, Farhad, et al.
Publicado: (2019)

P01-030 – Proteinuria in FMF – prediction of nephropathy type
por: Kukuy, OL, et al.
Publicado: (2013)

PW01-010 – The effect of pregnancy on disease course in FMF
por: Eviatar, T, et al.
Publicado: (2013)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF
por: van der Hilst, J, et al.
Publicado: (2015)

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF
por: Gul, A, et al.
Publicado: (2015)

OR7-005 – Canakinumab in childhood colchicine resistant FMF
por: Hashkes, PJ, et al.
Publicado: (2013)

P01-032 – Characterization of genetic-negative FMF
por: Ben-Zvi, I, et al.
Publicado: (2013)

FMF: an update
por: Ozen, Seza
Publicado: (2014)

Developing of a new scale for assessing the adherence to colchicine treatment in pediatric patients with FMF
por: Yesilkaya, S, et al.
Publicado: (2015)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

PW01-007 – Colchicine brand switching in FMF patients
por: Jagger, J, et al.
Publicado: (2013)

PW01-005 – Effects of placebo and colchicine on FMF patients
por: Özaltın, F, et al.
Publicado: (2013)

Colchicine intolerance in FMF patients and primary obstacles for optimal dosing
por: SATIŞ, Hasan, et al.
Publicado: (2020)

The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine resistant or intolerant FMF
por: Hashkes, P, et al.
Publicado: (2015)

Screening for Fabry’s disease in a high-risk subpopulation of FMF
por: Maller, Tomer, et al.
Publicado: (2022)

PW01-025 – Definition of colchicine resistance in FMF
por: Demirkaya, E, et al.
Publicado: (2013)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
por: Hashkes, PJ, et al.
Publicado: (2011)

P01-033 – Co-occurance of Crohn’s disease and FMF
por: Epstein, A, et al.
Publicado: (2013)

Activation of the pyrin inflammasome through the RhoA signaling pathway in FMF and HIDS
por: Park, YH, et al.
Publicado: (2015)

How safe it is to treat pregnant FMF patients with Anakinra?
por: Ozdogan, H, et al.
Publicado: (2015)

PW01-006 – The effect of colchicine on physical growth in FMF
por: Cakar, N, et al.
Publicado: (2013)

PW01-002 – Colchicine resistant FMF in Turkish children
por: Eroglu, FK Kara, et al.
Publicado: (2013)

PW01-015 – Canakinumab in adults with colchicin resistant FMF
por: Gül, A, et al.
Publicado: (2013)

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
por: El Hasbani, Georges, et al.
Publicado: (2019)

PReS-FINAL-2328: Developing and validating the new severity score for FMF
por: Demirkaya, E, et al.
Publicado: (2013)

PReS-FINAL-2218: Treatment of colchicines resistant FMF: experience of a pediatric center in Turkey
por: Kara Eroglu, F, et al.
Publicado: (2013)

PReS-FINAL-2204: Developing of a new scale for assessing the adherence to colchicines treatment in pediatric patients with FMF
por: Yesilkaya, S, et al.
Publicado: (2013)

Colchicine treatment can be discontinued in a selected group of pediatric FMF patients
por: Cohen, Keren, et al.
Publicado: (2023)

P01-009 – 2 years of colchicine IV in intractable FMF
por: Kaly, L, et al.
Publicado: (2013)

P01-043 – Comparative characteristic of FMF and FMF with HSP
por: Sargsyan, H, et al.
Publicado: (2013)

How long is the diagnosis of Familial Mediterranean Fever (FMF) delayed in a region where FMF is common in Turkey?
por: Karaaslan, Y, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fv82fn6f4198q5m86d6ktbcpce